Marcus M Schittenhelm Selected Research

Marcus M Schittenhelm Research Topics

5	Neoplasms (Cancer) 07/2022 - 01/2006
3	Leukemia 07/2022 - 01/2013
2	Carcinogenesis 01/2021 - 01/2013
1	Rhabdomyosarcoma 07/2022
1	Sarcoma (Soft Tissue Sarcoma) 07/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Lymphoid Leukemia 01/2013
1	Mucositis 08/2009
1	Cardiotoxicity 08/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2009
1	Seminoma 01/2006
1	Systemic Mastocytosis 01/2006

3	Protein Isoforms (Isoforms)IBA 07/2022 - 01/2006
2	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2013
2	Dasatinib (BMS 354825)FDA Link 02/2018 - 01/2006
1	RNA (Ribonucleic Acid)IBA 07/2022
1	ParaffinIBA 07/2022
1	Decitabine FDA Link 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	RetinoidsIBA 01/2020
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	5' Untranslated Regions (5' UTR)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	AnthracyclinesIBA 01/2013
1	tandutinibIBA 08/2009
1	AntibodiesIBA 03/2009
1	matuzumabIBA 03/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2009
1	ErbB Receptors (EGF Receptor)IBA 03/2009
1	Codon (Codons)IBA 01/2006
1	Imatinib Mesylate (Gleevec)FDA Link 01/2006
1	Phosphotransferases (Kinase)IBA 01/2006